Current Drug Targets

Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Abstract Ahead of Print

ACE2 as a key target for treatment of COVID-19 related cardiovascular diseases: current progress and prospect

Volume:22
Shuainan Li, Benzhi Cai*, Wenya Ma, Fan Yang, Yan Xu and Binbin Xu

Impaired Quality Control of Mitochondria Underlying the Pathogenesis of Alzheimer's Disease

Volume:22
Md. Sahab Uddin*, Umme Tabassum Arobi Katha and Ghulam Md Ashraf*

Review of the biological activity of maslinic acid1

Volume:22
Zhang Jing*, Wang Rui, Li Ruihua, Yu Hao and Fang Hengtong

Mitochondrial Dysfunction in Huntington’s disease: Pathogenesis and Therapeutic Opportunities

Volume:22
Aditi Sharma, Tapan Behl*, Lalit Sharma, Lotfi Aelya and Simona Bungau

Role of GSK-3 in Cardiac Health: Focusing on Cardiac Remodeling and Heart Failure

Volume:22
Ubaid Tariq, Shravan Kumar Uppulapu and Sanjay K Banerjee*